Interleukin-10 and prostaglandin E₂ have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma

• Eva Brencicova,

  Current address: Institute of Forensic Medicine, University of Bern, Bern, Switzerland

  Affiliation Peter Gorer Department of Immunobiology, Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, United Kingdom

  ⨯
• Ann L. Jagger,

  Affiliation Peter Gorer Department of Immunobiology, Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, United Kingdom

  ⨯
• Hayley G. Evans,

  Affiliations Peter Gorer Department of Immunobiology, Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, United Kingdom, Centre for Molecular & Cellular Biology of Inflammation (CMCBI), Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, United Kingdom

  ⨯
• Mirella Georgouli,

  Affiliation Peter Gorer Department of Immunobiology, Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, United Kingdom

  ⨯
• Alex Laios,

  Affiliation Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom

  ⨯
• Steve Attard Montalto,

  Affiliation Department of Gynaecological Oncology, St Thomas’ Hospital, London, United Kingdom

  ⨯
• Gautam Mehra,

  Affiliation Department of Gynaecological Oncology, St Thomas’ Hospital, London, United Kingdom

  ⨯
• Jo Spencer,

  Affiliation Peter Gorer Department of Immunobiology, Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, United Kingdom

  ⨯
• Ahmed A. Ahmed,

  Affiliation Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom

  ⨯
• Shanti Raju-Kankipati,

  Affiliation Department of Gynaecological Oncology, St Thomas’ Hospital, London, United Kingdom

  ⨯
• Leonie S. Taams,

  Affiliations Peter Gorer Department of Immunobiology, Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, United Kingdom, Centre for Molecular & Cellular Biology of Inflammation (CMCBI), Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, United Kingdom

  ⨯
• Sandra S. Diebold

  * E-mail: sandra.diebold@nibsc.org

  Current address: National Institute for Biological Standards and Control (NIBSC), Potters Bar, United Kingdom

  Affiliation Peter Gorer Department of Immunobiology, Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, United Kingdom

  ⨯